<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is characterized by the presence of arterial or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> or <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e> in a patient with positive laboratory tests for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (anticardiolipin antibodies and/or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and/or anti-beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I) </plain></SENT>
<SENT sid="1" pm="."><plain>Despite the strong association between <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> and obstetric morbidity, their pathogenic role in the development of these clinical features has not been fully elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>However, the knowledge of new pathogenic mechanisms might identify novel therapeutic targets and therefore may improve the management of these patients </plain></SENT>
</text></document>